Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects ; volume:15 ; number:1 ; day:10 ; month:4 ; year:2023 ; pages:1-19 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (10.4.2023), 1-19, 12.2023

Creator: Zhang, Wei
Young, Juan I.
Gomez, Lissette
Schmidt, Michael A.
Lukacsovich, David
Varma, Achintya
Chen, X. Steven
Martin, Eden R.
Wang, Lily

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-023-01216-7

URN: urn:nbn:de:101:1-2023082509245926544296

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhang, Wei
Young, Juan I.
Gomez, Lissette
Schmidt, Michael A.
Lukacsovich, David
Varma, Achintya
Chen, X. Steven
Martin, Eden R.
Wang, Lily
SpringerLink (Online service)

Other Objects (12)

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Related objects

Reset password